| Samantha P Flanagan, DO | |
|
120 Valley Green Ln Ste 510, King Of Prussia, PA 19406-2080 | |
| (484) 324-7100 | |
| (484) 324-7660 |
| Full Name | Samantha P Flanagan |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 120 Valley Green Ln Ste 510, King Of Prussia, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912431529 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS019797 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Paoli Hospital | Paoli, PA | Hospital |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Healthcare | 1951215201 | 894 |
News Archive
SXC Health Solutions Corp. a leading provider of pharmacy benefit management (PBM) products and services, today announced that its informedRx PBM unit has been awarded a three-year contract valued at approximately $240 million per year with a large Health Plan based on the U.S. east coast.
Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.
More than 936 million people have obstructive sleep apnea – the disease's first prevalence update in more than a decade – according to The Lancet Respiratory Medicine, the world's leading journal in its field.
While researchers around the world race to develop an effective and safe COVID-19 vaccine, a team from the San Diego Supercomputer Center (SDSC) at UC San Diego contributed to a study led by Vanderbilt Vaccine Center of Vanderbilt University Medical Center (VUMC) on T cell receptors, which play a vital role in alerting the adaptive immune system to mount an attack on invading foreign pathogens including the Coronavirus SARS-CoV-2.
› Verified 8 days ago
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
SXC Health Solutions Corp. a leading provider of pharmacy benefit management (PBM) products and services, today announced that its informedRx PBM unit has been awarded a three-year contract valued at approximately $240 million per year with a large Health Plan based on the U.S. east coast.
Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.
More than 936 million people have obstructive sleep apnea – the disease's first prevalence update in more than a decade – according to The Lancet Respiratory Medicine, the world's leading journal in its field.
While researchers around the world race to develop an effective and safe COVID-19 vaccine, a team from the San Diego Supercomputer Center (SDSC) at UC San Diego contributed to a study led by Vanderbilt Vaccine Center of Vanderbilt University Medical Center (VUMC) on T cell receptors, which play a vital role in alerting the adaptive immune system to mount an attack on invading foreign pathogens including the Coronavirus SARS-CoV-2.
› Verified 8 days ago
| Entity Name | Temple Faculty Practice Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881176949 PECOS PAC ID: 0345588711 Enrollment ID: O20190208002623 |
News Archive
SXC Health Solutions Corp. a leading provider of pharmacy benefit management (PBM) products and services, today announced that its informedRx PBM unit has been awarded a three-year contract valued at approximately $240 million per year with a large Health Plan based on the U.S. east coast.
Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.
More than 936 million people have obstructive sleep apnea – the disease's first prevalence update in more than a decade – according to The Lancet Respiratory Medicine, the world's leading journal in its field.
While researchers around the world race to develop an effective and safe COVID-19 vaccine, a team from the San Diego Supercomputer Center (SDSC) at UC San Diego contributed to a study led by Vanderbilt Vaccine Center of Vanderbilt University Medical Center (VUMC) on T cell receptors, which play a vital role in alerting the adaptive immune system to mount an attack on invading foreign pathogens including the Coronavirus SARS-CoV-2.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samantha P Flanagan, DO 120 Valley Green Ln Ste 510, King Of Prussia, PA 19406-2080 Ph: (484) 324-7100 | Samantha P Flanagan, DO 120 Valley Green Ln Ste 510, King Of Prussia, PA 19406-2080 Ph: (484) 324-7100 |
News Archive
SXC Health Solutions Corp. a leading provider of pharmacy benefit management (PBM) products and services, today announced that its informedRx PBM unit has been awarded a three-year contract valued at approximately $240 million per year with a large Health Plan based on the U.S. east coast.
Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.
More than 936 million people have obstructive sleep apnea – the disease's first prevalence update in more than a decade – according to The Lancet Respiratory Medicine, the world's leading journal in its field.
While researchers around the world race to develop an effective and safe COVID-19 vaccine, a team from the San Diego Supercomputer Center (SDSC) at UC San Diego contributed to a study led by Vanderbilt Vaccine Center of Vanderbilt University Medical Center (VUMC) on T cell receptors, which play a vital role in alerting the adaptive immune system to mount an attack on invading foreign pathogens including the Coronavirus SARS-CoV-2.
› Verified 8 days ago
Dr. Sharon Marie O'brien, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 625 Clark Ave Ste 13, King Of Prussia, PA 19406 Phone: 610-265-8566 Fax: 610-878-2620 | |
Dr. Jeanvickey Lusk, M.d., M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 Gypsy Lane, King Of Prussia, PA 19406 Phone: 215-200-8447 | |
Charissa Gardner Myers, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 S Henderson Rd Ste 306, King Of Prussia, PA 19406 Phone: 610-265-0726 Fax: 601-265-3132 | |
Kimberly A Richardson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 Mall Blvd, Ste 102, King Of Prussia, PA 19406 Phone: 610-265-0726 Fax: 610-265-3132 | |
Andrew A Badulak, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 S Henderson Rd, Ste 308c, King Of Prussia, PA 19406 Phone: 610-337-3111 Fax: 610-337-3506 | |
Dr. Weiguo Victor Li, MD, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 Clark Ave Ste 17a, King Of Prussia, PA 19406 Phone: 610-768-7168 Fax: 610-768-7169 | |
P. Michael Glowacki, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 Mall Blvd, Ste 102, King Of Prussia, PA 19406 Phone: 610-265-0726 Fax: 610-265-3132 |